feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Cancer Survival Boost: 320,000 More Lives Saved

Cancer Survival Boost: 320,000 More Lives Saved

4 Feb

•

Summary

  • Goal: 75% of patients to live well five years post-diagnosis by 2035.
  • Plan includes £2.3 billion investment in tests and scanners.
  • NHS aims to meet all cancer waiting time targets by 2029.
Cancer Survival Boost: 320,000 More Lives Saved

The UK has unveiled a comprehensive 10-year national cancer plan, setting ambitious goals to enhance patient survival and treatment outcomes. A key objective is to increase the five-year survival rate to 75% for patients diagnosed from 2035, a significant rise from the current 60%, potentially saving an additional 320,000 lives over the plan's duration.

To achieve these aims, the NHS has committed to meeting all its cancer waiting time targets by 2029. This includes faster diagnostic tests and an expansion of robot-assisted surgery. A £2.3 billion investment will fund 9.5 million additional tests by 2029, increasing scanner capacity and digital technology.

Furthermore, the plan targets 80% of patients to be diagnosed or have cancer ruled out within 28 days of referral by March 2026, and 96% to commence treatment within 31 days of a decision to treat. Specialist cancer centres will also play a larger role in treating rare cancers, with genomic testing offered to eligible patients.

trending

ChatGPT outage reported today

trending

Gemini imports ChatGPT chats

trending

AI music generator platform

trending

Tanker stalls Mumbai-Pune expressway

trending

HAL out of stealth jet

trending

Lakers beat Nets, 112-100

trending

India vs South Africa warm-up

trending

HDFC Bank share price target

trending

2026 Winter Olympics details

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The main goal is to increase the five-year survival rate to 75% for patients diagnosed from 2035, up from the current 60%, and to save an additional 320,000 lives.
The plan includes a £2.3 billion investment for 9.5 million additional tests by 2029, more scanners, digital technology, and an expansion of robot-assisted surgery.
The NHS has committed to meeting all its cancer waiting time targets by 2029.

Read more news on

Healthside-arrow

You may also like

Cancer Surges in Young Adults: Diet, Lifestyle Blamed

9 hours ago • 4 reads

article image

NHS England Lowers Bowel Cancer Test Threshold

26 Jan • 48 reads

article image

UK Partnership Turns Uranium into Cancer Drugs

16 Dec, 2025 • 223 reads

article image

NHS Launches World-First Liquid Biopsy for Cancer

14 Dec, 2025 • 232 reads

article image

King Charles' Cancer Fight: Precautionary Treatment Ahead

13 Dec, 2025 • 287 reads

article image